Cargando...
Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma Cells
[Image: see text] P-Glycoprotein is a well-known drug transporter associated with chemotherapy resistance in a number of cancers, but its role in modulating proteasome inhibitor efficacy in multiple myeloma is not well understood. The second-generation proteasome inhibitor carfilzomib is thought to...
Guardado en:
| Publicado en: | ACS Pharmacol Transl Sci |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American
Chemical Society
2021
|
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8033612/ https://ncbi.nlm.nih.gov/pubmed/33860196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00200 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|